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Abstract
Features of the CRISPR-Cas system, in which bacteria integrate small segments of phage
genome (spacers) into their DNA to neutralize future attacks, suggest that its effect is not limited
to individual bacteria but may control the fate and structure of whole populations. Emphasizing
the population-level impact of the CRISPR-Cas system, recent experiments show that some bac-
teria regulate CRISPR-associated genes via the quorum sensing (QS) pathway. Here we present a
model that shows that from the highly stochastic dynamics of individual spacers under QS control
emerges a rank-abundance distribution of spacers that is time-invariant, a surprising prediction
that we test with dynamic spacer-tracking data from literature. This distribution depends on the
state of the competing phage-bacteria population, which due to QS-based regulation may coexist
in multiple stable states that vary significantly in their phage-to-bacterium ratio, a widely used
ecological measure to characterize microbial systems.
1 Introduction
Complex communities of microorganisms are important ecological forces in almost every environment
from hot springs [1] to humans [2, 3, 4, 5, 6]. Phages, viruses which infect bacteria, are integral
components of microbial populations: phage predation has been shown to strongly influence bacterial
evolution, diversity, and numbers [7, 8]. To counter phages, bacteria have evolved many and complex
immune mechanisms [9]. CRISPR-Cas is one such defense mechanism which is both adaptive and her-
itable, i.e. it not only learns from past infections but also passes this knowledge to future generations.
Many models have addressed the effects of CRISPR-Cas on microbial populations, but a conceptual
vacuum remains: What experimental features of natural populations should be measured to compare
with model predictions?
CRISPR-Cas machinery for adaptive immunity allows bacteria to acquire unique genetic elements
(called spacers) from prior phage encounters to specifically target and evade recurrent attacks. The
spacers are 10s of nucleotides long, and at each encounter may be acquired from any of the 100s
of possible locations on the infecting phage genome (called protospacers). Since individual spacers
are distinguishable and because they are integrated in the genome, the result is a lineage of cells
that can be identified by its spacer(s). The fate of an individual lineage, however, is subject to
large fluctuations due to the stochastic dynamics of individual bacteria in a large rapidly evolving
population. Experiments show that the abundance of individual spacers in a bacterial population
under phage attack is indeed highly dynamic and varies over several orders of magnitude from one
spacer to the next [10, 11, 7, 12, 13]. This leads to a natural question: What controls spacer diversity
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and abundance; in other words, how does recurrent phage attack alter the structure and composition
of interacting spacer-marked lineages in a bacterial population?
Several previous models have addressed the role and dynamics of observed diversity of spacer types
[14, 15, 16, 17, 18, 19, 20, 21] in a qualitative way: (1) how system parameters such as phage adsorption
rate [21], spacer acquisition rate [16, 21], and phage mutation and recombination [18] affect spacer
diversity, (2) how increasing diversity promotes population stability [16, 19], and (3) have reproduced
the observed asymmetry in diversity along the locus in natural populations [14, 15, 18] by modelling
biased acquisition at the leader end of the CRISPR locus. Most recently, Bradde et al. [20] showed
a connection between spacer acquisition rates and spacer effectiveness to spacer diversity. To make a
direct connection with data, we analyzed sequencing data from Paez-Espino et al. [12], a co-evolution
experiment with phage and bacteria which tracked spacer dynamics. Our analysis shows that despite
rapid turnover of individual spacer types the spacer rank-abundance distribution quickly stabilizes,
which is a new and striking observation that previous models have not addressed.
Recently, similar questions about diversity in the adaptive immune system have gained traction
in the context of vertebrates which generate and maintain a large population of specialized immune
cells that, as a group, contain an extremely diverse set of binding sites that individually recognize
different viruses. Like spacer abundance, the abundance of individual binding sites is highly variable
[22, 23, 24]. This observation has led to the suggestion that a broad abundance distribution of
binding sites may strike a balance between generating a rapid response against likely invaders with
capturing new invaders [24]. Although this is hard to test in vertebrates, laboratory experiments that
alter bacterial population composition synthetically show that bacteria are more successful at fending
off phages as their population-level spacer diversity increases [25]. How the dynamics of individual
bacterial lineages shape spacer diversity and how diversity in spacer sequences or types relates to
diversity in spacer abundances remains unanswered.
Beyond the role of individual spacer lineages in shaping population structure, recent experiments
have shown that bacterial populations exert top-down control on the CRISPR system: two species
of bacteria have been observed to regulate their CRISPR-Cas systems in response to cell density
[26, 27]. Interestingly, this control acts via the quorum sensing pathway, a pathway which also
controls population-level responses such as virulence. This suggests a different paradigm where the
effects of CRISPR-Cas need to be considered at the collective population level, rather than at the level
of individual cells. Previous population-level models have not addressed this effect [28, 29, 30, 31, 32,
33, 34, 35, 36, 20, 21, 37, 38], and modelling efforts addressing CRISPR-Cas regulation have focused
on the relevant gene circuits and production of transcribed spacers called CRISPR RNAs (crRNAs),
not on the population-level effects of regulation [39, 40, 41].
We build a model that addresses the two aforementioned fundamental and unaddressed aspects
of the CRISPR-Cas system: (1) our model shows how stable rank-abundance distributions may arise
despite rapid turnover of individual spacer types that are identical in their ability to provide immu-
nity, and (2) our model shows that density-dependent regulation of CRISPR-Cas admits a bistable
state at the population level where the phage-bacterial population can be stable with two different
configurations under the same external conditions. We further argue how having the knowledge of
spacer diversity along with bistable states may shed light on the fate of natural microbial populations.
Model
Adaptive immunity in bacteria is controlled by a set of Cas proteins, which in a nutshell accomplish
two different tasks. (1) When an invading phage inserts its genome into a bacterial cell but is not
successful in killing the bacterium, Cas proteins take a small piece of phage genome and insert it
into the bacterial genome at a specific site called the CRISPR locus. (2) During a subsequent phage
attack, the bacterium can use the information stored in the CRISPR locus to recognize the invading
phage and neutralize it. Multiple spacers can be stored at a CRISPR locus, providing a genetic record
of immunization that is inherited during DNA replication. The immunization record in principle can
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be read via next generation sequencing and provides a rich presence/absence observable: the binary
variable sijk indicating whether spacer type i is in locus position j in host bacterium k (Figure 1A,
SI equation 2).
We model the abundance of the ith spacer, niB(t), which is obtained by summing over all bacteria
and locus positions, i.e. niB(t) =
∑
j,k sijk(t). An important simplifying assumption of our model
is that each locus has at most one spacer, i.e. j = 1; this assumption is borne out of analysis of a
laboratory experiment that shows that spacer dynamics stabilize rapidly within tens of generations
with each bacterium predominantly having one new spacer (see SI section A.2 for details of data
analysis) [12]. Additionally, a model that allowed more than one spacer also found that only the
most recently acquired spacers dominate the dynamics [16]. With this assumption, the abundance
of individual spacer types can be mapped to the number of bacteria with a particular spacer, niB .
In addition, we assume each spacer to have equal effectiveness; this is both a simplifying assumption
and also acknowledges our lack of experimental knowledge about differences among spacers and their
effectiveness.
To capture the inherent stochastic nature of spacer dynamics, we model the probability distribution
P (n0B , {niB}, nV , C, t), which is the probability at time t of observing n0B bacteria without spacers,
{niB} bacteria with spacer type i, nV phages, and a nutrient concentration of C. Interactions included
in the model are illustrated in Figure 1B and described in detail in SI section B. This construction
highlights another important simplifying assumption which is also valid for short timescales: lack of
phage diversity, i.e. all phages are assumed to be identical. In addition, we model the phage-bacteria
population in a flow cell or chemostat, a well-stirred vessel in which nutrients flow in at a constant rate
and concentration and the mixture flows out with the same rate. A chemostat is not only comparable
to periodic dilution experiments in the laboratory, it is also a reasonable approximation of real-world
microbial populations from a gutter to a gut. In many of these natural environments, nutrients and
waste flow in and out — the environment is not static like a petri dish. Additionally, the chemostat
flow rate F is an experimental “knob” that can be used to tune a population-level bifurcation we
describe later.
Our stochastic model has a corresponding mean-field or population-level description for average
values of the different random variables, each represented by the same symbol as their corresponding
random variable. At the mean-field level, all the spacer-containing bacteria can be pooled into a single
variable nsB =
∑
i n
i
B , and the number of bacteria without spacers is n
0
B . The mean-field equations
are given below. Parameter descriptions can be found in Figure 1 and SI Table 1. We assume that the
bacterial growth rate is linear with the concentration of nutrients C; relaxing this assumption does
not qualitatively change our results (see SI section C.2).
dC
dt
= FC0︸ ︷︷ ︸
flow in
− gC(nsB + n0B)︸ ︷︷ ︸
bacterial growth
− FC︸︷︷︸
flow out
dnV
dt
=−αnV (nsB + n0B)︸ ︷︷ ︸
phage adsorption
+αBpV nV (n
s
B(1− e) + n0B)︸ ︷︷ ︸
phage burst and bacterial lysis
−FnV (1)
dn0B
dt
=gCn0B − αpV nV n0B − α(1− pV )ηnV n0B︸ ︷︷ ︸
spacer acquisition
+ rnsB︸︷︷︸
spacer loss
−Fn0B
dnsB
dt
=gCnsB − αpV (1− e)nV nsB + α(1− pV )ηnV n0B − rnsB − FnsB
Results
1.1 Mean-field steady-states
For phages to invade a bacterial population that is stable in a chemostat, their probability of success-
fully infecting bacteria without the benefits of adaptive immunity, pV , needs to be above a certain
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Figure 1: (A) CRISPR locus: Small (∼ 30 nt) samples of invasive phage DNA called spacers (colored
rectangles) are incorporated into the CRISPR genetic locus. Spacers are separated by short (∼ 30
nt) sequences called repeats (black diamonds). Multiple spacers can be stored at a CRISPR locus,
resulting in a genetic record of immunization [42]. In our analysis of the experimental data shown
in Figure 3A-C, we identify spacers with a type i, a locus position j, and a bacterium k. (B) In our
model, bacteria and phages interact in a chemostat (flow cell) with a constant inflow and outflow
rate F . Nutrients flow into the chemostat at a fixed concentration C0. Phages are assumed to be
identical with a large, fixed number of possible protospacers. Phages adsorb to bacteria with rate
α and successfully infect and kill naive bacteria with probability pV . Each bacterium can acquire a
single spacer (j = 1). Spacers are tracked in the population as the number of bacteria containing a
spacer of type i, niB . If a naive bacterium survives an infection, it can acquire a spacer with probability
η. All spacers are assumed to be equally effective: the probability of phage success in an infection is
reduced by e if a bacterium has a spacer. Bacteria with spacers revert to naive bacteria by losing a
spacer with rate r.
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Figure 2: (A) Bacteria, phage, and nutrients at steady state as a function of the probability of phage
success pV for a model without CRISPR (spacer effectiveness e = 0, solid lines) and for a model where
bacteria have CRISPR systems and are able to acquire spacers (e = 0.5, dashed lines). Population
sizes are normalized by the inflow nutrient concentration C0, and phages are additionally scaled by the
burst size B. As the probability of phage success pV increases, bacteria decrease in number. Below
pV = p
0
V , phages cannot persist and the fraction of bacteria with spacers is 0. Phages increase with
increasing pV and then decrease at high pV because the bacterial population is too small to support
more phages. (B) Normalized total bacteria as a function of spacer acquisition probability η and
spacer effectiveness (equal for all spacers). (C) Fraction of bacteria with spacers (ν) as a function of
η and e.
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minimum value given by p0V =
1
B
(
gf
(1−f)α + 1
)
, where f = F/(gC0). For
gf
(1−f)α << 1 (satisfied at the
parameters we use for low flow rates), p0V is approximately 1/B: phages must succeed approximately
every 1/B interactions in order to persist in the population. p0V is surprisingly small for realistic values
of the burst size B; for example if B = 100, then p0V ≈ 0.01. As pV rises above the threshold value,
the steady-state phage population, nV , first rises while the bacterial population decreases as they get
killed by phages. Interestingly, the steady-state bacterial population keeps decreasing with increasing
pV , but the phage population exhibits a non-monotonic behavior with a maximum population size at
an intermediate value of p?V = p
0
V +
√
p0V
f (p
0
V − 1B ). This steady-state behavior is qualitatively the
same for bacteria with adaptive immunity (e > 0) as for bacteria without adaptive immunity (e = 0).
Quantitatively, however, bacteria always fare better in the presence of adaptive immunity (Figure 2A).
One surprising observation is that the minimum success probability required for phages to invade a
bacterial culture is independent of adaptive immunity. This is because there are no bacteria with
spacers at steady state below pV = p
0
V , and as a result, phage invasion occurs independently of the
CRISPR system (SI Figure 17).
Much like increasing pV , an increasing spacer effectiveness e causes the total number of bacteria
at steady-state to increase monotonically (Figure 2B), since a bacterium with a spacer is less likely
to be killed by phages as e increases. However, even for e > 0, not all bacterial cells in a population
have a spacer, and the steady state fraction of the bacterial population with spacers, ν, is governed
by a balance of spacer acquisition, η spacer loss, r, and the effect of e on the bacterial population.
As a result, the steady-state level of bacteria can increase by either increased spacer acquisition or
improved spacer effectiveness; contours in Figure 2B show the tradeoff between η and e that maintains
bacterial population size.
In contrast to total bacterial population, ν first increases as e increases but reaches a maximum at
an intermediate value of e (Figure 2C). This can be understood as ν qualitatively tracking the phage
population size, which shows a peak at intermediate spacer effectiveness (SI Figure 19). Qualitatively,
this behavior is similar to the total phage population having a non-monotonic behavior with increasing
pV .
1.2 Spacer rank-abundance distributions
Even at steady-state with stable populations of phage and bacteria, the individual spacer abundances
in the bacterial population are highly dynamic and vary significantly over time. This has been seen
most directly in laboratory experiments [12, 13] but has also been observed in natural samples such
as a hypersaline lake [43], human saliva [44], and acid mine drainage [10, 15]. This continual spacer
turnover is influenced by bacterial reproduction and death, spacer acquisition, and spacer loss, all of
which have been observed in natural and laboratory populations.
In our stochastic model, we keep track of individual spacer acquisition and loss events. Not
surprisingly, we find that spacer abundances fluctuate over time (see Figure 3D, Figure 3E, and SI
section D.1). However, we also find that the spacer rank-abundance distribution reaches a stationary
state from an initial state with no spacers, shown in Figure 3F and SI section B.5. Not only does the
spacer distribution in our simple model reach a stationary state while individual spacers turn over
rapidly, it also shows 1000-fold variation in spacer abundances despite the fact that all spacers are
functionally identical in our model and provide resistance to the same phage. The exact shape of the
distribution depends on various parameters (see SI section B.5) and is well-approximated by a gamma
distribution which has been used to describe species abundance distributions in ecology [45, 46, 47, 48]
(SI section B.6).
To test predictions with data, we analyzed experimental data reported by Paez-Espino et al. [12]
from a bacterial population under constant phage attack. We summarized their raw sequencing data
into the presence/absence tensor sijk as shown in Figure 1A, and we tracked dynamics of individual
spacers niB(t) =
∑
j,k sijk(t). Our analysis showed that the abundance of individual spacer types
fluctuated throughout the 15 days (∼ 80 generations) of the experiment (Figure 3A), with more than
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Figure 3: Comparison of spacer distributions between simulations (D-F) and experimental data from
[12] (A-C). (A) and (D) Subset of spacer type trajectories over time in generations for experimental
data (A) and simulated data with η = 10−5 and e = 0.387 (D). Qualitative simulation results are
insensitive to the choice of e and η. Individual spacer abundances fluctuate throughout the experiment
and simulation. (B) As a function of time difference at steady-state (Day 4 / generation 26 onwards),
we calculated the fraction of spacer types that have gone extinct (blue points), averaged over all
times (red line). Error bars are standard deviation. (E) Same as (B) but for simulated data from
generation 300 to 500. A large fraction of spacer types go extinct during the course of the experiment
and simulation. Inset: fraction of spacer types that go extinct for a long simulation from generation
500 to 3000. The fraction that go extinct continues to increase with time. (C) The rank-abundance
distribution of spacer clone sizes reaches a steady state in the experiment after about 20 generations
(Day 3 of the experiment). Darker blue indicates later times. (F) The distribution of spacer clone
sizes reaches a steady state in the simulation after about 100 generations. Plotted is the same quantity
as in (C). Even after the distribution of clone sizes has reached steady state, individual spacer types
experience continual turnover.
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Figure 4: Bacterial upregulation of cas gene expression at high density can induce bistability (yellow
shaded area) as a function of the normalized chemostat flow rate f = F/(gC0), a parameter that is
easy to tune experimentally. The blue shaded region is monostable, and in the pink shaded region
phages cannot persist. (A) The bacterial population size (solid black lines) exhibits hysteresis (blue
arrows) between a low-expression, low-density state and a high-expression, high-density state. (B)
The spacer rank-abundance distribution shape depends on the ecological state of the population.
Plotted are two rank-abundance distributions from simulations of the high and low expression states
respectively; population sizes for each distribution indicated by dots in (A). Inset: linear frequency
scale.
40% of spacers going extinct within a time difference of a few generations from any starting time
(Figure 3B). In contrast, we find that the spacer rank-abundance distribution reaches a stationary
state, as shown in Figure 3C. Notably, the rank-abundance distribution is broad with some spacers
having a roughly 1000-fold higher abundance than others. However, in contrast to the intuition
that highly abundant spacers may be more effective, these high-abundance spacers also experience
continual turnover, shown in SI Figure 21 (SI section D). Both the simulated and experimental data
show similar mean times to extinction as a function of spacer abundance (SI section D.1), another
indication of continual spacer turnover at steady-state.
In general our analysis highlights that individual spacer identity and abundance may not themselves
be important but collectively may provide a time-invariant observable in the form of steady-state rank-
abundance distributions. And somewhat counterintuitively, spacers need not be functionally different
in their effectiveness or acquisition probability to get large variability in spacer abundances.
1.3 Regulation of cas expression
Merely having an effective spacer, however, is not enough: to effectively neutralize phage, bacteria
need to express cas genes when under attack. Experimental work has shown that bacteria can regulate
their CRISPR-Cas systems in response to cell density, controlled under the quorum sensing pathway
[26, 27]. A cell increases its expression of Cas proteins at high cell density in response to a high
concentration of quorum sensing molecules and down-regulates its expression of Cas proteins at low
cell density. To understand the role of cell density-dependent regulation of the CRISPR-Cas system,
we made spacer effectiveness e to be a function of cell-density: e(x) = emin + (emax− emin)
(
xn
xn+xn0
)
,
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where x is the normalized bacterial population size. This function is characterized by three numbers:
minimum effectiveness, emin, maximum effectiveness, emax, and typical population size where the
behavior changes from low to high effectiveness (see SI section E). Regulation of cas genes may also
alter other parameters of the model such as acquisition, spacer loss, and growth rates, but we show
in SI section E.3 that adding regulation to other possible parameters independent of effectiveness
has little effect, and that in conjunction with density-dependent effectiveness they do not change the
qualitative features we describe below.
Notably, the dependence of spacer effectiveness on population size changes both the number and
value of the steady-state fixed points. We find that the whole bacteria-phage-nutrient system under-
goes a saddle-node bifurcation and is bistable for a range of parameters. The bistability results from
a positive feedback that is established under QS control of the CRISPR-Cas system but is absent
otherwise: the total bacterial population size increases with increasing spacer effectiveness, and in
turn effectiveness increases as CRISPR-Cas is upregulated by higher bacterial density (SI Figure 25).
There are various parameters that can be used as the bifurcation parameter, but one that can be eas-
ily controlled in experimental systems and perhaps plays a role in natural systems is the normalized
chemostat flow rate f = F/(gC0), which can also be thought of as the inverse of nutrient availability.
Figure 4 shows how bacterial and phage abundance varies as flow rate is changed in the presence of
density-dependent regulation of the CRISPR-Cas system. At the two extremes, for low flow rate the
system behaves with no adaptive immunity and bacterial (and phage) population size is low, while at
high flow rate adaptive immunity kicks in and bacteria can maintain a higher population size. The
phage population remains low at high flow rate both because bacteria are more resistant and because
phages are removed from the system at a higher rate. At very high flow rate, phages go extinct and
the bacterial population starts decreasing linearly with flow rate. For intermediate flow rate, the low
and high states are both stable, allowing the system to be in either state. In principle these two
population-level states could coexist and interact.
This bistable system may also exhibit hysteresis, which may have important ecological conse-
quences, possibly functioning as a memory of past phage pressure or providing a switch-like behavior
between “on” and “off” states of the CRISPR system. Not only can the phage-to-bacterium ratio
(called VPR) be significantly different between the two states but spacer composition and diversity
can also be quite different (see Figure 4B and SI section B.5).
Our model exhibits bistability quite generically for large parameter ranges but requires choosing
an appropriately steep function for effectiveness (see discussion in SI section E).
Discussion
CRISPR-Cas is a unique system in that adaptive immunity is both hereditary and acquired. Its
impacts on population dynamics are thus unlike any other immune system, and experimental ob-
servations must be interpreted with theory specific to the CRISPR-Cas system. Our analysis of
experimental data yielded a striking result: rank-abundance spacer distributions are stable over time
paralleling population-level stability, despite what looks like ongoing turnover in the abundances of
individual spacer types. This overall stability suggests a need for a population-level approach in which
questions about spacer diversity are addressed alongside questions about CRISPR-Cas regulation. In
this framework, communities of bacteria function collectively more like a single organism capable
of complex signalling and behavior than like a collection of individual bacteria undergoing selective
dynamics.
In this work, we propose and analyze a simplified model of interacting bacteria and phage in
which bacteria regulate the CRISPR-Cas system in a density-dependent way, which in turn controls
the spacer-marked clonal composition of the bacterial population under phage attack. We find that
the bacteria-phage population exhibits bistability with the possibility of co-existence between two
ecologically different states. These two stable states may differ by orders of magnitude in the phage-
to-bacterium ratio as well as differing in the spacer diversity and composition of the population.
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Our model also provides a framework where large variability in spacer abundance may arise due to
population dynamics rather than due to individual parameters of spacers, since our model is neutral
with no selective advantage for particular spacers. And finally, our model shows how a stable spacer
rank-abundance distribution may emerge while individual spacer types turn over rapidly.
Sequencing provides an easy way to track spacers, which in turn provide a direct record of past
interactions between a bacterium and its phages. Although there has not been much effort towards
spacer tracking in individual bacteria, population-level spacer dynamics is becoming readily accessible
both from laboratory experiments [12, 13, 38] and natural populations [7, 10]. In the laboratory, both
large variability and rapid turnover of individual spacer types have been observed. Understanding
these dynamics is certainly interesting but requires much higher sampling and resolution than what
is currently available [49]. Also, acquiring such data, especially time-resolved, for natural systems
such as microbial mats and acid mine drainage may not be practical. Here we show that the spacer
rank-abundance distribution may provide a more useful time-invariant observable for understanding
the underlying dynamics in both natural and laboratory systems; our work predicts that measuring
spacer abundances in natural populations may reveal abundance distributions that are stable in time
and potentially indicative of the environmental conditions despite differences on the level of spacer
sequences between populations and over time.
Even without phage diversity and phage mutations in our model, we reproduce important features
of the spacer dynamics observed in recent laboratory experiments [12]. In the presence of mutant
phages, the net effectiveness of different spacers in providing immunity against phages may vary from
one spacer to the next. We expect that a spacer’s effectiveness will depend on the fraction of the
phage population with a matching protospacer. This fitness difference between spacers will have
consequences for the population dynamics, and some aspects have been addressed in experiments
[50, 51, 13] and models [16, 31, 52, 33, 32, 19, 38] and reviewed in [53].
Multistability at the level of cellular states, where a fraction of the population switches to an
alternate state, has been explored at length with implications from bet-hedging to lytic-lysogenic
switching to antibiotic resistance and persistence [54, 55, 56, 57, 58]. Similarly-structured populations
are now being explored in contexts from healthy regenerating tissues to pathologies such as cancer
[59]. While recent models for large interacting microbial populations using a statistical mechanical
approach [60, 61, 62, 63] show that ecological multistability akin to what is seen in a spin glass may be
present in such populations, they remain experimentally inaccessible. A notable exception is Gore et
al., who observed population-level bistability and coexistence between two cooperating yeast strains in
a mixed culture [54]. Here we provide one of the first examples of multistable, multispecies ecological
states that may be readily accessible in experiments. We show that for a population of bacteria and
phages the flow rate of a chemostat or dilution rate of a serially diluted population can serve as a
bifurcation parameter. Since both nutrient concentration (which controls population density) and
dilution rate are easy to control experimentally, ecological states in our phage-bacteria population
should be readily accessible (see SI section E.4).
In natural populations where phages and bacteria coexist, the phage-to-bacterium ratio, also called
virus-to-prokaryote ratio (VPR), has been measured and reported for a wide range of conditions.
While viruses are generally assumed to outnumber bacteria by a factor of ten [66, 8, 67, 34], the
measured ratio can vary between samples by as much as a factor of 106 [64]. The underlying factors
and ecological significance of observed VPR values are not well understood. Our model predicts a
variable phage-to-bacterium ratio for different parameters. Notably, the VPR for the low-expression
branch of the bistable system is approximately ten times higher than for the high-expression branch
(Figure 5A). These values reflect the two underlying ecological states: VPR is low when bacteria are
at high density and upregulate CRISPR-Cas expression, and VPR is high when bacteria are at low
density and have turned down CRISPR-Cas expression. This suggests that low observed VPR values
may be indicative of an active bacterial defense system, while high VPR may correspond to a bacterial
population strongly controlled by phages. With deep metagenomic sequencing it will be possible to
measure VPR in natural environments for phage-bacteria species pairs that are known to interact,
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Figure 5: (A) The phage-to-bacterium ratio (virus-to-prokaryote ratio, VPR) can differ by more than
ten-fold between the two bistable states in the model (solid black lines). These values reflect the two
underlying ecological states: VPR is low when bacteria are at high density and upregulate CRISPR-
Cas expression, and VPR is high at low bacterial density and low CRISPR-Cas expression. (B)-(D)
VPR histogram and fitted log-normal distributions for organisms from eutrophic (high nutrient),
mesotrophic (moderate nutrient), and oligotrophic (low nutrient) environments (data from Parikka et
al. [64]). We fit one-dimensional Gaussian mixture models with one and two Gaussian distributions
respectively to the data and chose the best-fitting model (blue line) using the Akaike Information
Criterion (AIC). The data was fit better by a single Gaussian distribution for the eutrophic data (∆
AIC = 45.7) and two Gaussian distributions for the mesotrophic (∆ AIC = 10.2) and oligotrophic
data (∆ AIC = 8.1). For each fit, we calculated the likelihood that the not-chosen model was a better
fit: e−∆AIC/2 [65]. This likelihood is 1.2×10−10, 0.006, and 0.017 for the eutrophic, mesotrophic, and
oligotrophic data respectively.
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shedding more light on the significance of phage pressure in natural microbial communities.
In our model, the normalized chemostat flow rate f is inversely proportional to the inflow nutrient
concentration C0, which suggests that the model’s VPR predictions and the ecological conditions
under which CRISPR-Cas is advantageous may be impacted by nutrient availability. A study by
Payet and Suttle [68] found that phage production and phage-induced mortality of bacteria were both
highest in marine samples when the water was most productive and nutrient-rich, while lysogens were
more common when the water was oligotrophic. This is also consistent with the finding that phage
infection risk is higher at high bacterial density [69, 70, 26].
To connect this qualitative feature of our model to natural populations, we analyzed VPR data
from Parikka et al. [64] and found that the distribution of measured VPR values appears bimodal
in low and moderate nutrient environments. It may be the case that at high nutrient levels where
bacteria live in dense communities and are at high risk of lytic phage predation, most or all bacteria
employ a highly-expressed CRISPR-Cas system and VPR is peaked at a single low value in that
environment (Figure 5B). Conversely, at low to moderate nutrient levels, different bacteria may use
different immune strategies and so VPR values may span a wider range (Figure 5C-D). Note that
at very low f and high nutrient availability, our model predicts monostability in the low-density,
low-expression stable state corresponding to high VPR, yet we observe a unimodal low VPR in high
nutrient environments (Figure 5B). In these conditions when phages are a large threat, bacteria may
use another signal besides density to upregulate the CRISPR-Cas system. In this work we provide
an intuitive connection between an observed quantity such as VPR and a non-trivial insight into the
ecological state of interacting bacteria and phages.
2 Methods and Materials
Data Analysis
We analyzed data from an experiment in which S. thermophilus bacteria were mixed with phages
and sequenced to track the expanding portion of the CRISPR locus over fifteen days [12] by labelling
spacers with a type i corresponding to a unique spacer sequence, a locus position j, and a bacteria
label k. All spacers within an edit distance of 2 from each other were grouped into the same type.
See SI section A for details.
We compared data reported by Parikka et al. [64] with our model. When plotting VPR values,
we combined average VPR measurements and individual VPR measurements (‘VPR av’ and ‘VPR’
columns) to create a combined dataset of VPR values.
Our processed data can be found on GitHub at https://github.com/mbonsma/CRISPR-immunity.
Model Analysis
The mean-field model was solved exactly at steady state in Mathematica. Steady-state values with
regulation added were calculated numerically. See SI section C for stability analysis.
Simulations
Simulations were written in C++ and performed using the tau leaping method [71]. See SI sec-
tion B.3 for details. Simulation code can be found on GitHub at https://github.com/mbonsma/
CRISPR-immunity.
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A Data analysis
We used data from [12] which is publicly available in the NCBI Sequence Read Archive under the acces-
sion SRA062737. It includes four data files (SRR630110, SRR630111, SRR630412, and SRR630413)
which we used for our analysis. We extracted the data corresponding to the MOI2 deep sequencing
experiment and separated it into time points by checking each read for matches to the primers identi-
fied in the supplementary information of [12]. Any reads with a mismatch between the annotation of
the forward and reverse primers were discarded. Any remaining unsorted reads were excluded from
the following analysis.
A.1 Identifying and sorting spacers
We extracted and catalogued spacers from the published raw read data of [12]. Since only the ex-
panding CRISPR end was sequenced, each read represents the longest possible sequence from wild
type to leader end and so further assembly was not required (SI Figure 6 and SI Figure 7).
Because of this very specialized data structure, detecting CRISPR spacers and inferring their
order was conceptually straightforward. A spacer was defined as any sequence flanked by two repeats.
Since each read was bordered by wild type sequence and leader end sequence, all repeat sequences
were complete and not truncated. SI Figure 7 shows a typical read in more detail. Note that in
this orientation, the spacer numbered “1” is found at the end of the read. To collect spacers, we
(1) detected repeat sequences, reversing the read if the repeats were reversed, (2) inferred spacers as
sequences between repeats, and (3) categorized spacers by comparing to previously detected spacers.
Repeat sequence variation was present due to sequencing errors or naturally occurring SNPs. We
used a regular expression to match variations on the number of Ts in a 5-T region of the repeat - the
forward repeat was matched with ”GTTT*GTACTCTCAAGATTTAAGTAACTGTACAAC” and the
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Figure 6: Schematic of the portion of the S. thermophilus CRISPR locus sequenced in [12]. We
identified spacers with a type i, a locus position j, and bacteria number k. Coloured rectangles to
the right of the dashed line represent spacers sequenced as the locus expands. Wild type spacers are
shown in greyscale.
ATCAGACACGGAAAGTAAGGATTGACAAGGACAGTTATTGATTTTATAATCACTATGTGGGTATAA
AACGTCAAGATTTTATTTGAGGTTTTTGTACTCTCAAGATTTAAGTAACTGTACAACCCAACACTC
AAACGTTGCAAACGCAAGCTTGTTTTTGTACTCTCAAGATTTAAGTAACTGTACAACATCACTTAC
GAGGTTGACGGTTTTGTAGATGTTTTTGTACTCTCAAGATTTAAGTAACTGTACAACTGTTTGACA
GCAAATCAAGCGTGTCTGATCTGAGCGGGCTGGCAAGGCGCATAGN
CRISPR repeat, forward primer, reverse primer, spacer
Figure 7: Example read covering the expanding CRISPR locus. The forward primer which overlaps
with the leader sequence is shown in blue italics. The reverse primer which overlaps the first wild type
spacer is shown in green italics. CRISPR repeats are shown in bold red and spacers in bold black.
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reverse repeat was matched with ”GTTGTACAGTTACTTAAATCTTGAGAGTACAAA*C”. These
expressions match an identical string with three or more Ts or As in the region of the asterisk. This
is a reasonable allowance to make since the 454 sequencing platform used to sequence this data is
known to have high insertion and deletion rates in homopolymer regions [72].
To detect the most possible spacers, we developed methods to deal with repeat sequence variation
beyond simple insertions and deletions in the homopolymer region. We inferred the presence of an
undetected repeat by measuring the length of sequence before the first detected repeat, after the last
detected repeat, and between two repeats. If any of these lengths exceeded its threshold (determined
based on the known primer lengths and average spacer length, respectively), a more careful search
for repeats was performed using the pairwise2 module in Biopython which performs a local pairwise
alignment between the ideal repeat sequence and the read in question.
A.1.1 Pairwise alignment settings
If the alignment with the true repeat (36 nucleotides long) was less than 31 nucleotides long, the
alignment was discarded. The scoring system was as follows: match score of 1, mismatch score of -1,
gap open score of -0.8 for the target sequence, gap open score of -0.7 for the repeat, and gap extend
penalty of -1 for each sequence. The gap open scores were chosen to be different for the repeat and
read so that the algorithm could identify how many gaps were opened and in which each sequence, in
order to properly identify the start and end of each spacer.
If no good match was found in a region between two repeats, the remaining “long” spacer was
discarded and a placeholder was inserted to preserve position information. Using this method, the
number of detected repeats increased from 550931 to 622067, a 12.9% increase.
Repeats detected in this second search sometimes contained gaps with respect to the read or vice
versa. In these cases, conventional labelling of nucleotide position prevented accurate detection of
the start and end of adjacent spacers. We detected how many gaps were present and whether they
occurred in the repeat or the read and then adjusted the indices of adjacent spacers accordingly. The
scoring scheme was carefully chosen so that the number and placement of gaps could be inferred from
the score.
A.1.2 Spacer type assignment
We compared newly detected spacers to a growing list of previously detected spacers to assign it a
type. If it matched an existing spacer exactly, it was assigned that type. Otherwise, a global pairwise
alignment was performed between the new spacer and all existing spacers. If a match was found for
which the score subtracted from the spacer length was within a chosen cutoff, the new spacer was
assigned that type. This definition of cutoff is equivalent to the number of allowed SNPs between
spacers under the scoring scheme used. If no match was found in either case, the new spacer was
assigned a new type.
To choose an appropriate tolerance for spacer alikeness, we tested this spacer sorting algorithm
on a small sample of data (190 reads) as the cutoff was increased from 0 to 9. SI Figure 8 shows the
number of unique spacer types detected as the cutoff is changed. It can be seen that there is a clear
plateau between cutoff values of 1 and 8, which indicates that the system is insensitive to the cutoff
if it falls in this range. We chose a cutoff of 2 for the analysis.
In this way, we created a master dataset for each time point that contained each detected spacer, a
number indicating the source read, the spacer position in the read, and the assigned spacer type. The
definition of spacer type was consistent across time points, or in other words the same comparison list
was carried through all time points.
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Figure 8: Number of unique spacer types vs. cutoff for 190 reads from time point 11. The green
vertical dashed line indicates the selected cutoff.
A.2 Analysis
We extracted CRISPR spacers from the raw reads at each time point by finding sequences flanked by
an S. thermophilus CRISPR repeat (SI Figure 6). Newly detected spacers were added to an existing
group if they were within an edit distance of 2 of another spacer in that group. Data was organized
into an array sijk (equation 2).
sijk(t) =
{
1 if spacer type i is at position j in bacterium k
0 otherwise
(2)
We tracked individual spacer types, or “clones”, niB(t), by summing over all bacteria and all locus
positions: niB(t) =
∑
j,k sijk(t).
Most bacteria acquired only a single spacer; over half of bacteria from days 4-14 which had acquired
1 or more spacers only acquired a single spacer (SI Figure 9).
B Model description
We model bacteria and phages interacting in a chemostat. The populations we track are nutrient
concentration C, phages nV , and bacteria nb which can either have no spacer (n
0
b) or a spacer of type
i (nib). Nutrients flow in at concentration C0 with rate F , and all species flow out with rate F . The
total number of bacteria with a spacer is nsb and the total number of bacteria is nB . The phage in
the solution are all clonal and have m distinct protospacers. Bacteria grow at rate gC. With rate α,
a phage interacts with a bacterium. With probability pV , the phage will kill bacteria without spacers
and produce a burst of new phages with size B, while for bacteria with spacers that probability is
reduced to psv = (1− e)pV (0 ≤ e ≤ 1). Bacteria without spacers that survive an attack have a chance
to acquire a spacer with probability η. Bacteria with a spacer lose their spacer at rate r. Parameter
descriptions and default values are shown in SI Table 1.
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Figure 9: Total number of spacers at each time point in the experiment. Position 1 represents the
oldest spacer (closest to the wild type spacers). Over half of all bacteria that acquired spacers, even
at the end of the experiment, only acquired a single spacer.
B.0.1 Reactions
Table 2 lists all the interactions present in our model between individual bacteria (b), phages (V ) and
nutrients (C).
22
Table 1: Model parameters
Parameter Description Value
1
gC0
Bacterial doubling time 41.7 min
C0 Inflow nutrient concentration in
units of bacterial cell density
α Phage adsorption rate 2× 10−10 min−1
B Phage burst size 170
F Chemostat flow rate
pV Probability of phage success
for bacteria without spacers
e Spacer effectiveness
r Rate of spacer loss
η Probability of spacer acquisition
Parameter values are as above unless otherwise indicated. Representative values estimated for
Streptococcus thermophilus bacteria in lab conditions.
Table 2: Model reactions
b0,i + C
g−→ 2b0,i bacterium divides
b0,i
F−→ ∅ bacterium flows out
V
F−→ ∅ phage flows out
∅ FC0−−−→ C nutrients flow in
C
F−→ ∅ nutrients flow out
b0 + V
αpV−−−→ BV interaction, phage wins
b0 + V
α(1−pV )(1−η)−−−−−−−−−→ b0 interaction, bacterium survives
b0 + V
α(1−pV )η/m−−−−−−−−→ bi interaction, bacterium survives and acquires a spacer
bi + V
αpsv−−→ BV interaction, phage wins
bi + V
α(1−psv)−−−−−→ bi interaction, bacterium survives
bi
r−→ b0 bacterium loses spacer
B.1 Master equation
The reactions in Table 2 can be formulated as a master equation describing the probability of observing
n0b bacteria without spacers, the set n
i
b bacteria with spacers of type i, nV phages, and a nutrient
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concentration of C at time t (equation 3).
dP (n0b , {nib}, nV , C, t)
dt
= g(C + 1)(n0b − 1)P (n0b − 1, {nib}, nV , C + 1, t)
+
m∑
j=1
g(C + 1)(njb − 1)P (n0b , {ni 6=jb }, njb − 1, nV , C + 1, t)
+ F (n0b + 1)P (n
0
b + 1, {nib}, nV , C, t)
+
m∑
j=1
F (njb + 1)P (n
0
b , {ni6=jb }, njb + 1, nV , C, t)
+ F (nV + 1)P (n
0
b , {nib}, nV + 1, C, t)
+ F (C + 1)P (n0b , {nib}, nV , C + 1, t)
+ FC0P (n
0
b , {nib}, nV , C − 1, t)
+ αpV (n
0
b + 1)(nV −B + 1)P (n0b + 1, {nib}, nV −B + 1, C, t)
+ α(1− pV )(1− η)n0b(nV + 1)P (n0b , {nib}, nV + 1, C, t)
+
m∑
j=1
α(1− pV )η
m
(n0b + 1)(nV + 1)P (n
0
b + 1, {ni 6=jb }, njb − 1, nV + 1, C, t)
+
m∑
j=1
αpsv(n
j
b + 1)(nV −B + 1)P (n0b , {ni 6=jb }, njb + 1, nV −B + 1, C, t)
+
m∑
j=1
α(1− psv)njb(nV + 1)P (n0b , {ni 6=jb }, njb, nV + 1, C, t)
+
m∑
j=1
r(njb + 1)P (n
0
b − 1, {ni6=jb }, njb + 1, nV , C, t)
−
F (n0b + m∑
j=1
njb + nV + C + C0) + gC(n
0
b +
m∑
j=1
njb)
+αnV (n
0
b +
m∑
j=1
njb) + r
m∑
j=1
njb
P (n0b , {nib}, nV , C, t)
(3)
The 1st term is included only for n0b > 1, the 2nd term if n
j
b > 1, the 7th term for C ≥ 1, 8th term
if nV > B − 1, the 10th term for njb ≥ 1, the 11th term for nV > B − 1 and the 13th term for n0b ≥ 1.
B.2 Mean-field dynamics
We can also write equations for the averages of the microscopic quantities (equations 4 to 7).
B.2.1 Microscopic equations
d
〈
n0b
〉
dt
= −F 〈n0b〉+ g 〈Cn0b〉− αpV 〈n0bnV 〉− α(1− pV )η 〈n0bnV 〉+ m∑
j=1
r
〈
njb
〉
(4)
d
〈
njb
〉
dt
= −F
〈
njb
〉
+ g
〈
Cnjb
〉
− αpsv
〈
njbnV
〉
− r
〈
njb
〉
+
α(1− pV )η
m
〈
n0bnV
〉
(5)
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d 〈nV 〉
dt
=− F 〈nV 〉+ αpV (B − 1)
〈
n0bnV
〉− α(1− pV ) 〈n0bnV 〉+
m∑
j=1
αpsv(B − 1)
〈
njbnV
〉
−
m∑
j=1
α(1− psv)
〈
njbnV
〉 (6)
d 〈C〉
dt
= F (〈C〉 − C0)− g
〈
C
n0b + m∑
j=1
njb
〉 (7)
We approximate the correlations 〈XY 〉 ≈ 〈X〉 〈Y 〉.
d
〈
n0b
〉
dt
= −F 〈n0b〉+ g 〈C〉 〈n0b〉− αpV 〈n0b〉 〈nV 〉 − α(1− pV )η 〈n0b〉 〈nV 〉+ m∑
j=1
r
〈
njb
〉
(8)
d
〈
njb
〉
dt
= −F
〈
njb
〉
+ g 〈C〉
〈
njb
〉
− αpsv
〈
njb
〉
〈nV 〉 − r
〈
njb
〉
+
α(1− pV )η
m
〈
n0b
〉 〈nV 〉 (9)
d 〈nV 〉
dt
=− F 〈nV 〉+ αpV (B − 1)
〈
n0b
〉 〈nV 〉 − α(1− pV ) 〈n0b〉 〈nV 〉+
m∑
j=1
αpsv(B − 1)
〈
njb
〉
〈nV 〉 −
m∑
j=1
α(1− psv)
〈
njb
〉
〈nV 〉
(10)
d 〈C〉
dt
= F (〈C〉 − C0)− g 〈C〉
〈n0b〉+ m∑
j=1
〈
njb
〉 (11)
Then, we replace means by deterministic variables n0b , n
j
b, nV , and C.
dn0b
dt
= −Fn0b + gCn0b − αpV n0bnV − α(1− pV )ηn0bnV +
m∑
j=1
rnjb (12)
dnjb
dt
= −Fnjb + gCnjb − αpsvnjbnV − rnjb +
α(1− pV )η
m
n0bnV (13)
dnV
dt
= −FnV + αpV (B − 1)n0bnV − α(1− pV )n0bnV
+
m∑
j=1
αpsv(B − 1)njbnV −
m∑
j=1
α(1− psv)njbnV
(14)
dC
dt
= F (C − C0)− gC
n0b + m∑
j=1
njb
 (15)
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Figure 10: Total bacteria (nB) and total phage (nV ) as a function of time for a Gillespie simulation
and a tau leaping simulation. The two simulation techniques produce very similar results.
B.2.2 Macroscopic equations
We can define new variables, nsb =
∑m
j=1 n
j
b, nB = n
0
b + n
s
b, ν = n
s
B/nB (1 − ν = n0B/nB), and
psV = (1− e)pV .
dn0b
dt
= −Fn0b + gCn0b − αpV n0bnV − α(1− pV )ηn0bnV + rnsb (16)
dnsb
dt
= −Fnsb + gCnsb − α(1− e)pV nsbnV − rnsb + α(1− pV )ηn0bnV (17)
dnV
dt
= −FnV − αnBnV + αpV (1− eν)BnBnV (18)
dC
dt
= F (C − C0)− gCnB (19)
dnB
dt
= −FnB + gCnB − αpV (1− eν)nBnV (20)
B.3 Description of simulations
Simulations were written in C++ and performed on a Lenovo ideapad Y700 and on SciNet. We
primarily used the tau leaping method [71] and compared with Gillespie simulations for some cases.
Both methods showed good agreement for the mean-field behaviour of bacteria and phages (SI Figure
10) and produced the same qualitative behaviour for individual spacer types (SI Figure 11).
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Figure 11: Comparison of individual spacer type trajectories using tau leaping and Gillespie simulation
techniques. (A) 10 spacer type trajectories vs time using Gillespie simulation methods. (B) 10 spacer
type trajectories vs time using tau leaping simulation methods.
B.4 Parameter choices
Burst size for phage that target S. thermophilus is between 140-200 [73]. The rate of adsorption for
phage is of the order of 10−8 min−1 ml [74]. Using a volume of V = 50ml, our total adsorption rate
is α = 2× 10−10 min−1 per bacteria and phage.
[75] measured the maximum growth rate of S. thermophilus in milk at 42◦C to be 2.4×10−2 min−1.
This corresponds to gC0 in our model.
The other parameters were picked in order to get a stable fixed point where phage and bacteria
coexist, with population sizes relevant to experiments such as [12].
B.5 Simulation results
Our simulations were performed with a maximum of m = 500 spacer types that can be acquired by
bacteria. This upper limit on the number of spacer types limits the total diversity of spacer types
that can be observed and only impacts the spacer abundance distribution at large η. The qualitative
simulation results, namely a continuous turnover of individual spacers and the presence of a non-trivial
steady-state spacer abundance distribution, are insensitive to the choice of η provided not all m spacer
types are acquired. This puts an upper bound on η of ≈ 10−4 in our simulation, but simulations with
higher η can be performed with large values of m. SI Figure 12 shows the average total number of
unique spacer types at steady state as a function of η for simulation data, compared to the analytic
prediction given by equation 30: the number of unique spacer types predicted at steady state is
∑
k bk.
We initialized each simulation with no bacteria with spacers, or in other words the rank-abundance
distribution is uniform at 0 abundance at the start of all simulations. The steady-state distribution
evolves from a very different shape at early times. SI Figure 13 shows the spacer rank-abundance
distribution for various time points of a simulation run.
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Figure 12: The average number of unique spacer types present at steady-state in simulations (circles
and solid lines) increases with increasing η. The simulation results are well-matched by the analytic
prediction from equation 30 (triangles and dashed lines). The parameters η and e were chosen for each
simulation so that all points on each colored curve correspond to a constant total bacterial population
size of 0.15C0 (blue points), 0.1C0 (green points) and 0.05C0 (red points).
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Figure 13: Spacer rank-abundance distributions for a simulation with η = 10−5 and e = 0.387. Time
is rescaled into units of bacterial generations. (A) The distribution at early times begins as a flat
distribution with a few bacteria having a single spacer (0.1 generations). As time progresses, more
bacteria acquire spacers and some spacer types grow to larger sizes, making the distribution steeper
and broader. (B) At longer times, the distribution reaches its steady-state shape at about generation
200.
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B.6 Origin of rank-abundance curve
The spacer rank-abundance distribution resulting from our simulations can be analytically derived
from the following master equation, which describes bk, the number of spacer types, or clones, of size
k. The size of a clone can increase through bacterial division with rate gC (first term) or decrease
through flow (F ), spacer loss (r), and phage predation (αnV pv(1 − e)). The third term in equation
21 describes spacer acquisition: since in our simulations the total number of protospacers is fixed
at m = 500, a newly acquired spacer will be added to an existing clone of size k with probability
η/m, where η is the probability of acquiring any spacer in an interaction in which the phage does not
succeed (which happens with probability 1− pV ).
∂tbk = gC[(k − 1)bk−1 − kbk] + (F + r + αnV pV (1− e))[(k + 1)bk+1 − kbk]
+αn0bnV (1− pV )
η
m
[bk+1 − bk]
(21)
The variables nV , n
0
B , and C evolve according to their mean-field equations (16, 18, 19). The total
number of bacteria with spacers nsB =
∑
k kbk; ∂t
∑
k kbk is equivalent to equation 17.
At steady-state, all the population variables are constant, and equation 21 can be solved using a
generating function and the method of characteristics.
B.6.1 Generating function solution
The generating function for the probability distribution bk(t) is G(z, t) =
∑
k z
kbk(t).
Let β = gC, µ = F + r + αnV pV (1− e), and D = αηn0BnV (1− pV ). Multiplying equation 21 by∑
k z
k and noting that ∂zG(z, t) =
∑
k kz
k−1bk(t), we get the following differential equation:
∂tG(z, t) = ∂zG(z, t)
(
z2β − z(β + µ) + µ)+G(z, t)D
m
(z − 1) (22)
Equation 22 can be solved with the method of characteristics [76]. We parametrize the function
G(z, t) with a new variable s. Applying the chain rule:
∂sG(z(s), t(s)) =
∂G
∂z
∂z
∂s
+
∂G
∂t
∂t
∂s
(23)
And by comparison with equation 22, the characteristic equations are
∂t
∂s
= 1 (24)
∂z
∂s
= (1− z)(βz − µ) (25)
∂G
∂s
= G
D
m
(z − 1) (26)
From equation 24 we see t = s + c1, so we can choose t0 = c1 = 0 and replace s with t going
forward.
Solving the characteristic equation for z by integrating both sides gives equation 27.
1− z
µ− βz e
(β−µ)t = c2 (27)
At t = 0, z will pass through some point z0, so we have the initial condition z(0) = z0. With z0
in equation 27 at t = 0, we get equation 28, where c2 is given by equation 27.
z0 =
c2µ− 1
c2β − 1 (28)
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The variation of G along the z − t curve is
∂G
∂z
= −
GD
m (z − 1)
z2β − z(β + µ) + µ = −
GD
m(βz − µ)
Integrating both sides, we get
G(z) = Ω(c2)(βz − µ)− Dβm
The constant Ω is a function of the characteristic z-t curve (equation 27). To find the particular
form of Ω(c2), we apply the initial condition G(z, 0) = zN0, meaning that we start with N0 clones of
size 1 at time t = 0.
G(z, 0) = zN0 = Ω
(
1− z
µ− βz
)
(βz − µ)− Dβm
Let ξ = 1−zµ−βz , therefore z =
ξµ−1
ξβ−1 .
Ω(ξ)(β
(
ξµ− 1
ξβ − 1
)
− µ)− Dβm =
(
ξµ− 1
ξβ − 1
)
N0
Solving for Ω(ξ):
Ω(ξ) =
(
ξµ− 1
ξβ − 1
)
N0(β
(
ξµ− 1
ξβ − 1
)
− µ) Dβm
The full solution for G(z, t) can be written by replacing the constant Ω(c2) with the expression for
Ω(ξ) and replacing ξ with ξ, where  = e(β−µ)t is the time-dependent part of the z − t curve.
G(z, t) = N0(βz − µ)− Dβm
(
ξµ− 1
ξβ − 1
)
(β
(
ξµ− 1
ξβ − 1
)
− µ) Dβm
Finally, replacing ξ with 1−zµ−βz , we get
G(z, t) = N0(βz − µ)− Dβm
(
(1− z)µ+ βz − µ
(1− z)β + βz − µ
)
(β
(
(1− z)µ+ βz − µ
(1− z)β + βz − µ
)
− µ) Dβm
G(1, t) = N0, meaning that the total population remains conserved, consistent with our assumption
that all the population variables are at steady-state.
The limit as t→∞ of G(z, t) is
G(z) = N0
(
βz − µ
β − µ
)− Dβm
We can construct bk by taking successive derivatives of G(z): bk =
1
k!
∂G
∂z |z=0
bk =
N0
∏k
i=1[D/m+ (i− 1)β](µ−βµ )D/(βm)
k!µk
(29)
b0 = N0
(
µ− β
µ
)D/(βm)
We can re-write this expression using Stirling’s approximation for k! to facilitate evaluation at
large k.
bk =
N0√
2pik
exp
[
D
βm
ln
(
µ− β
µ
)
+
k∑
i=1
ln
(
e
kµ
(
D
m
+ (i− 1)β)
)]
(30)
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Figure 14: Equation 30 (dashed lines) compared with spacer clone size distributions from simulations
at steady-state (dots). (A) Distributions in cumulative form. (B) Distributions shown as a histograms
(dots). The analytic steady-state distribution matches well with the simulation results, except in the
cases where the acquisition rate η is very low and the choice of bin size has a large effect. Here
N0 = m, the total number of unique clones.
Equation 30 is an analytic expression describing the steady-state spacer abundance distribution
that results from our simulations. SI Figure 14 compares the analytic distribution to the steady-state
spacer clone size distribution from our simulations at several values of the spacer acquisition probability
η, with e chosen such that the total number of bacteria is the same for all cases. The corresponding
rank-abundance distribution can be obtained from the cumulative distribution (SI Figure 14A) by
flipping the axes and rescaling the frequency axis.
B.6.2 Rank-abundance distribution in ecology
The steady-state clone size distribution given in equation 30 can be approximated for large clone size
k and large m to give a gamma distribution and logseries distribution respectively, both of which have
a long history as descriptions of species abundance in ecology [77].
In the following expressions we replace N0 with m, since at steady-state the total number of clones
remains fixed at m.
We find the following expression for bk in the limit of large clone size (large k) by taking a series
expansion as k →∞ and keeping the first term.
bk ≈
m
(
1− βµ
) D
βm
Γ
(
D
βm
) e−ln(µ/β)k (1
k
)1− Dβm
(31)
This is a gamma distribution with shape parameter Dβm and rate parameter ln(µ/β). Note that(
1− βµ
) D
βm ≈ ln(µ/β) Dβm , consistent with the canonical form of the gamma distribution. The ad-
ditional factor of m in equation 31 arises because we treat bk as the number of clones of size k; to
normalize bk we would divide by m, the total possible number of unique clones.
The gamma distribution has been used to describe species abundance in a number of ecological
situations [45, 46, 47, 48]. For example, Dennis and Patil [45] arrive at a gamma distribution as “the
approximate stationary distribution for the abundance of a population fluctuating around a stable
equilibrium,” and Plotkin and Muller-Landau [48] use a gamma distribution to fit species abundance
distributions on a tropical island.
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For practical purposes the gamma distibution given by equation 31 is a good approximation to
the true distribution for all the parameter values we considered in our simulation.
When the total number of unique spacer types m is large, our model is effectively an infinite alleles
model in which each newly acquired spacer is assumed to be completely unique. In the limit of large
m, we find the following expression for bk.
bk ≈ D
β
1
k
(
β
µ
)k
(32)
Up to a constant, this is a log-series distribution, made famous by Fisher et al. [78] and appearing
many times since [79].
C Mean-field steady-state solutions
C.1 e = 0 model (no adaptive immunity)
Equations 16 to 19 describe the full model. If spacer effectiveness e = 0, the model reduces to three
dimensions: bacteria nB , phages nV , and nutrients C. Equations 33 to 35 describe this simpler model.
dnV
dt
= −αnBnV + αBpV nBnV − FnV (33)
dnB
dt
= gCnB − αpV nV nB − FnB (34)
dC
dt
= FC0 − gCnB − FC (35)
Solving equations 33 to 35 at steady state gives the following fixed points.
C.1.1 Trivial fixed point
There is a trivial fixed point where bacteria and phages are both zero.
n∗B = 0
n∗V = 0
C∗ = C0
The eigenvalues of the Jacobian at this fixed point are 1 − f,−f , and −f , where f = F/(gC0).
This means that this fixed point is stable for f > 1. f > 1 is a reasonable stability condition: this is
the case where the flow rate is too high for bacteria to persist.
C.1.2 Phages unable to persist
n∗B = C0(1− f)
n∗V = 0
C∗ = C0f
0 < f < 1 is required for physical existence of this fixed point.
The eigenvalues of the Jacobian at this fixed point are f − 1, −f , and − (f−1)p(BpV −1)+fpVpV , where
p = pV α/g. The first two are negative under the requirement for existence. The third is negative for
BpV <
gf
(1−f)α + 1. If this stability condition is satisfied, phages cannot persist in the population —
they will be driven to extinction.
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C.1.3 All populations finite and stable
If all variables are non-zero, the fixed point is
n∗B
C0
= fpVp(−1+BpV )
n∗V
C0
= (1−f)p(BpV −1)−fpVp(p(BpV −1)+pV )
C∗
C0
= p(BpV −1)p(BpV −1)+pV
The condition for existence is
BpV >
gf
(1−f)α + 1
The eigenvalues are
−f
−
√
f
√
4(f−1)p2(BpV −1)2+4fppV (BpV −1)+fp2V +fpV
2p(BpV −1)
√
f
√
4(f−1)p2(BpV −1)2+4fppV (BpV −1)+fp2V −fpV
2p(BpV −1)
The first is always negative. The second is negative for
4p2(BpV −1)2
(2p(BpV −1)+pV )2 ≤ f < 1
The third is negative for
4p2(BpV −1)2
(2p(BpV −1)+pV )2 ≤ f <
p(BpV −1)
p(BpV −1)+pV =
C∗
C0
The upper limit on f is the same as the existence condition (requiring all be solutions > 0).
C.2 Nonlinear bacterial growth rate
Instead of the growth rate for nB being gC, we check what happens when the growth rate is a Hill
function of the form gkCC+k , where k is the nutrient concentration at which bacterial growth rate is at
half maximum. If k >> C, the linear approximation used in our results is valid and gkCC+k ≈ gC.
Solving for the non-trivial steady-state variables in the case when bacteria have no CRISPR spacers,
we find that n∗B is unchanged:
n∗B =
F
α(BpV − 1) (36)
C∗ and n∗V , however, now depend on k:
C∗ =
1
2
(
C0 − k − gkn
∗
B
F
)
+
1
2
√(
C0 − k − gkn
∗
B
F
)2
+ 4C0k (37)
n∗V =
gkC∗
C∗ + k
− F (38)
This solution for C reduces to the linear growth rate solution (section C.1.3) when k is large. This
can be seen by expanding the square root in C∗ and keeping terms up to order 1k3 :
C∗
C0
≈ 1− 1
p(B − 1/pV ) +
1
p2(B − 1/pV )2 ≈
p(B − 1/pV )
p(B − 1/pV ) + 1
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Figure 15: Solid lines: solutions to equations 33 to 35 with linear growth for nB . Green dashed lines:
solutions to equations 36 to 38 for different values of k.
The stability condition for bacteria and phage coexistence now depends on k. k must be greater
than the following parameter combination in order for phages to persist.
k >
F (F + α(C0 −BC0pV ))
Fg + α(F − C0g)(BpV − 1) = C0
f(fg + α(1−BpV ))
fg + α(1− f)(1−BpV )
For f = F/(gC0) = 0.1, B = 170, pV = 0.02, g = 2.4 × 10−11, C0 = 109, and α = 2 × 10−10, k/C0
must be greater than ≈ 0.11. SI Figure 15 compares the full nonlinear growth solutions (equations
36 to 38) to the solutions for linear growth (equations C.1.3). Provided k is large enough that phages
can persist, the picture is not qualitatively different, and in the low-nutrient limit (k >> C), the two
solutions are very nearly the same.
C.3 e 6= 0 model (adaptive immunity)
If e > 0, then the system is fully four-dimensional and all four variables are coupled.
C.3.1 Trivial fixed points
The two partially trivial fixed points are the same as in the case when e = 0, since if nV = 0, then
ν = nsB/nB = 0 at steady state. The stability and existence conditions are also the same; effectively
ν becomes uncoupled and the system is reduced to three dimensions if nV = 0.
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C.3.2 Non-trivial fixed point
For convenience we define rescaled population sizes x = nB/C0, y = nV /C0, and z = C/C0. Solving
in the case where all dynamical variables are non-trivial, we get
z∗ =
p(BpV (eν
∗ − 1) + 1)
p(BpV (eν∗ − 1) + 1)− pV (39)
x∗ =
fpV
p
1
BpV (1− eν∗)− 1 (40)
y∗ =
(f − 1)p(BpV (eν∗ − 1) + 1)− fpV
p(eν∗ − 1)(p(BpV (eν∗ − 1) + 1)− pV ) (41)
And an implicit cubic equation for ν, where R = r/(gC0).:
0 = (1− ν) [−pV νe− η(1− pV )] [(1− f)p(pVB(1− eν)− 1)− fpV ]
+RνpV (1− eν)(BppV (1− eν)− p+ pV )
(42)
This cubic equation is analytically solvable, but the full solutions in terms of all parameters are
cumbersome.
Only one of the three solutions of equation 42 is physical in the parameter range we use (real-valued
and properly bounded):
ν∗ = −
(
1 + i
√
3
) 3√√
(−27a2d+ 9abc− 2b3)2 + 4 (3ac− b2)3 − 27a2d+ 9abc− 2b3
6 3
√
2a
+
(
1− i√3) (3ac− b2)
3 22/3a
3
√√
(−27a2d+ 9abc− 2b3)2 + 4 (3ac− b2)3 − 27a2d+ 9abc− 2b3
− b
3a
(43)
where the coefficients are
a = Be2fpp2V (f +R− 1) (44)
b = −efpV (p(f(B(pV (e+ η + 1)− η)− 1) (45)
+B(η − pV (e+ η − 2R+ 1))−R+ 1) + pV (f +R))
c = fp
[
Bp2V (e(f − 1)(η + 1) + (f − 1)η +R) (46)
− (e− 1)(f − 1)pV (Bη + 1)− (2B + 2)(f − 1)ηpV + (f − 1)η − pV (f +R− 1)]
+ fpV (efpV − fη + pV (fη +R))
d = −fη(pV − 1)((f − 1)p(BpV − 1) + fpV ) (47)
Total bacteria, phage, nutrients, and the fraction of bacteria with spacers are plotted for a range
of parameters in SI Figure 16 and SI Figure 19.
This fixed point is stable for a wide range of parameters, which we explored numerically. SI Figure
18 shows the number of negative eigenvalues vs. parameters; where all four eigenvalues have a negative
real part, this fixed point is stable.
We observed that the minimum success probability p0V =
1
B
(
gf
(1−f)α + 1
)
required for phages to
invade a bacterial culture is independent of e, which parametrizes adaptive immunity. To understand
this, note that the fraction of bacteria with spacers (ν = nsB/nB) = 0 whenever nV , the number of
phages is 0, since spacers are continually lost with a small rate r but cannot be acquired if there are
no phages. As a result, p0V is independent of e since there are no bacteria with spacers at the point of
phage extinction. SI Figure 17 shows ν and phages with and without adaptive immunity, illustrating
that both ν and nV go to zero at pV = p
0
V .
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C.3.3 Large α limit
For large α (α >> α0, where α0 =
gf
(1−f)(BpV −1) ), we can find an approximate value of e, e
∗, at which
ν and nV peak (equation 48). This solution is plotted as a yellow dashed line in SI Figure 19.
e∗ =
1
BpV
+
R(1−BpV )
BpV (f − 1)(1−B(η + pV ) +BηpV ) (48)
D Spacer dynamics
In our analysis of data from [12], we found that spacer abundance distributions were stable in time
after three days and were broad, spanning four orders of magnitude. This distribution ρ(v) is created
by summing all spacer types of a particular abundance: ρ(v) =
∑
i δ(n
i
B − v). The normalized
cumulative distribution,
∑∞
v ρ(v)/
∑∞
0 ρ(v), is plotted in SI Figure 20. The corresponding rank-
abundance distribution is plotted in Figure 3C in the main text.
Individual spacer types experience continual turnover, both in our simulations and in experimental
data from [12]. In the experimental data, both high-abundance and low-abundance spacers can change
in abundance by an order of magnitude or more between time points, while in our simulations we find
that the large abundance spacers are approximately stable once the system has reached a population-
level steady state (SI Figure 21).
The observed turnover in large spacer types in the experimental data may reflect additional stochas-
ticity not accounted for in our model, changes in fitness for individual spacer types over time, or the
fact that the sequenced spacers are strongly undersampled. There are ≈ 108 to 109 bacteria at the
end of each day in the experiment, and there are ≈ 3 × 104 spacers recovered from sequencing each
day. The data is undersampled by a factor of ≈ 104, and apparent turnover may result from this.
SI Figure 22 compares the original simulation data with data undersampled by a factor of 102, 103,
or 104. The mean fractional abundance over time for a particular type appears mostly unaffected by
the undersampling, but there is indeed more variability when the degree of undersampling is higher.
At an undersampling factor of 104, spacer counts are in the ones and tens, much lower than than
counts of ≈ 103 or 104 in the experimental data. Variability in the experimental data is over more
orders of magnitude between time points than in the undersampled simulated data.
This undersampling of simulated data only considered that fewer organisms are sequenced than
are present in the population and does not take into account that the experiment was performed with
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100:1 serial dilutions and so each time point was seeded with a random subsample from the previous
time point.
D.1 Time to extinction
To further investigate ongoing turnover in individual spacer types in our simulations and the exper-
imental data, we calculated the mean time to extinction as a function of spacer abundance. Only
data at steady state was used, beginning at Day 4 in the experimental data and generation 200 in the
simulated data. For each spacer type that went extinct during the simulation or experiment, the time
remaining to extinction was recorded as a function of its abundance at each time point after steady
state, and the average and standard deviation over all types were calculated at each abundance. Figure
23 shows the standard deviation envelope for simulated data overlaid with experimental data, indicat-
ing that for both simulations and experiment spacers continue to experience turnover at steady-state
and that the simulated time to extinction closely matches the experimental observations. Note that
the longest observed time to extinction can never exceed the length of the simulation or experiment,
meaning that shorter measurement windows will result in shorter average times to extinction. To
illustrate this effect we calculate two time to extinction distributions for a short simulation of similar
length to the experiment (generation 300 to 400) and a longer simulation (generation 300 to 500).
Figure 24 shows that the mean time to extinction is finite even for high abundance spacers in the
simulated data.
E Regulation of CRISPR-Cas
E.1 Extent of bistability
We add regulation of CRISPR-Cas to our model by making spacer effectiveness e a function of bacte-
rial cell density, assuming Cas expression to also be a sigmoidal function of cell density. Many bacterial
behaviours controlled by quorum sensing are threshold-dependent: cells must switch between discrete
states such as motile and non-motile, biofilm and free-living, virulent and non-virulent. In many quo-
rum sensing systems, production of the autoinducer molecule is under positive feedback and increases
nonlinearly with increasing cell density, and so many of the resulting changes in gene expression are
switch-like [80]. For this reason we assume that spacer effectiveness depends strongly on cell density.
However, we observe bistability for a wide range of parameters and note that spacer effectiveness
does not necessarily need to be a sharp function of x, where x = nB/C0. SI Figure 25 illustrates
the additional dependence of e on x — wherever e(x) intersects the original solution, there is a fixed
point. SI Figure 25B shows that even a linear e(x) can intersect the original solution in three places
for certain parameters, in this case for certain values of f . Any curve that intersects one of the solid
lines in three places will result in bistability.
Changing the precise location of the transition from low to high spacer effectiveness does not change
the existence of bistability, but it does cause an interesting bifurcation. SI Figures 26 and 27 show in
two and three dimensions what happens to the fixed points as the transition point x0 is scanned from
0 to 0.3. For a transition point at low cell density, the unstable fixed points are adjacent to the low
expression stable fixed points at one end and the high expression stable fixed points at the other end,
making hysteresis possible. However, as the transition point increases to higher cell density, the two
ends meet and form a closed loop with just the high expression state. In this situation, bistability
still exists, but the system can never jump from the low expression state to the high expression state
without being placed there since there is one continuous low expression stable state across the entire
range of f .
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Errorbars (blue lines) are standard deviation of mean time to extinction.
0.00 0.05 0.10 0.15 0.20 0.25
0.0
0.1
0.2
0.3
0.4
0.5
0.6
S
p
a
ce
r 
e
ff
e
ct
iv
e
n
e
ss
 e
Increasing f
A
x ∗ (e, f)
e(x)
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
0.0
0.2
0.4
0.6
0.8
1.0
B
e(x) sigmoid with n= 10
e(x) sigmoid with n= 1
e= 1. 2x+ 0. 2
Normalized total bacteria x
Figure 25: (A) The original dependence of bacterial population size at steady-state on spacer effec-
tiveness e and normalized flow rate f is plotted for three values of f (solid blue lines). We model
upregulation from quorum sensing by introducing a density-spacer effectiveness (dashed black line),
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Figure 26: Fixed points (bacterial population size) as a function of flow rate f for different values
of the transition point between low and high expression. As the transition point increases (lighter
colours), the bistability changes from an ‘S’ shape to a circle and a line. This bifurcation happens at
a transition point of approximately x = 0.15.
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Figure 27: Fixed points (bacterial population size and phage population size) as a function of flow
rate f for different values of the transition point between low and high expression.
E.2 Bistability across system variables
Bistability affects all four dynamical variables in our model. SI Figure 28 shows each variable at
steady state vs. flow rate f in a regime with bistability.
E.3 Adding regulation to acquisition, loss, and growth rate
We model CRISPR-Cas regulation by making spacer effectiveness density-dependent, but it is reason-
able that up-regulation of CRISPR-Cas would affect other system parameters as well. In particular,
spacer acquisition rates would likely increase since acquisition relies on the Cas protein machinery as
does interference [42]. Additionally, spacer loss is thought to happen by homologous recombination
and to occur in tandem with acquisition [50, 15].
We added a sharp sigmoidal density dependence to both spacer acquisition probability and spacer
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Figure 28: Bacteria x, phages y, nutrients z, and the fraction of bacteria with spacers ν as a function
of f in a parameter regime showing bistability. The solid black lines indicates a stable fixed point and
the dashed black line indicates an unstable fixed point.
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Figure 29: The dependence of bacterial population size x at steady-state on spacer effectiveness e when
r and η are both sharp functions of density (blue dots). A monotonic function for spacer effectiveness
as a function of x (green solid line) can still only intersect in at most three places, qualitatively giving
the same bistability result.
loss rate. SI Figure 29 shows the resulting steady-state bacterial population size as a function of spacer
effectiveness. The result is still monotonically increasing, which means that a monotonic function for
spacer effectiveness as a function of x can still only intersect in at most three places, qualitatively
giving the same bistability result.
Measurements of the fitness cost of CRISPR in Streptococcus thermophilus identified Cas protein
expression as having a fitness cost [81], making it reasonable that bacteria would down-regulate Cas
expression in times when CRISPR is not needed. [81] measured a selective advantage of 0.11 for S.
thermophilus with a cas9 or csn2 gene knockout in direct competition with wild type but did not
observe a difference in maximum growth rate. This definition of selective advantage corresponds to
the difference in average exponential growth rate per hour for each strain. We incorporated a Cas-
expression-dependent decrease in bacterial growth rate in our model and investigated its effect on
bistability. Here we model Cas expression as a theta function (discrete ‘off’ and ‘on’ states) with the
switch occurring at xC = 0.06 (arbitrarily chosen):
g(x) =
{
g1 x ≤ xC
g0 x > xC
(49)
The growth rate gC0 depends on the Cas expression state with g1C0 being the growth rate per
minute without Cas expression and g0C0 being the growth rate with Cas expression, where g0 < g1.
A selective advantage of 0.11 gives g0 = g1 − 0.11/(60C0).
SI Figures 30 and 31 show the resulting change in steady-state bacterial population size as a
function of spacer effectiveness for two different growth rate dependences on expression. For even a
50 percent reduction in growth rate at high Cas expression, the resulting curves are not qualitatively
altered, and as before, a monotonic curve for e(x) can intersect in at most three places to give
bistability.
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Figure 30: The dependence of bacterial population size x at steady-state on spacer effectiveness e
when g is a sharp function of cell density x. The value of x at which regulation is turned on or off
is indicated by the black dashed line. Lines are plotted for F instead of f = F/(gC0) because f
depends on g. Plotted is bacterial population size at steady state where the growth disadvantage for
Cas expression is g0 = g1 − 0.11/(60C0), calculated from the measured selection coefficient in [81].
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Figure 31: The dependence of bacterial population size x at steady-state on spacer effectiveness e
when g is a sharp function of cell density x. The value of x at which regulation is turned on or off
is indicated by the black dashed line. Plotted is bacterial population size at steady state where the
growth disadvantage for Cas expression is g0 = 0.5g1.
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Figure 32: The dependence of bacterial population size x at steady-state on spacer effectiveness e
in the model for different values of F and C0 (solid lines). For a given measured dependence of cas
expression on cell density (black dashed line, for example), F and C0 can tune whether the system is
monstable or bistable by changing the number of intersections between the two curves.
E.4 Experimentally measuring regulation
While we chose parameters that are reasonable for S. thermophilus, it is unlikely that our quantitative
results match experimental conditions for different organisms. Our prediction is that in an appropriate
parameter range, an experiment measuring bacterial population density as a function of flow rate may
exhibit hysteresis as the flow rate is first increased and then decreased, allowing the bacteria-phage
population to reach steady state after each change in flow rate. It is easy to imagine however that the
transition determining high or low Cas expression may not automatically align with the cell densities
in the chemostat. The first experimental step is to measure the true Cas expression as a function of
cell density for Pseudomonas, as done in [26]. In their experiment, cas3 expression increased by a
factor of about 10 for a 10-fold increase in cell density (from ≈ 8× 107 to ≈ 8× 108 CFU/mL).
Next, the concentration of nutrients in the inflow medium C0 can be used to tune the cell density
to one at which CRISPR would naturally be highly expressed at a high flow rate. Then the flow rate
F can independently tune the position along the bifurcation diagram in SI Figure 4. In this way an
experimental population of Pseudomonas can be tweaked to qualitatively align with our model.
SI Figure 32 shows the steady-state bacterial concentration vs. spacer effectiveness in our model
as C0 and F are varied. Provided the true Cas expression is a sharp enough function of density and
that the low expression state is below the plateau in effectiveness in SI Figure 32, it will be possible
to choose C0 and F such that the system is bistable. The position of the plateau in effectiveness
at which the bacterial density changes sharply is controlled by BpV : as BpV increases, the plateau
moves to higher effectiveness. B and pV are properties specific to the phage and may change with the
particular phage species used.
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E.4.1 Significance of regulation in natural populations
In natural populations, multiple states may define different ecological niches as seen in structured
populations from microbial mats [1] to the human microbiome [82]. Biofilms are an example of both
dense and structured communities of bacteria and are found in many natural environments such as
hot springs [1] and acid mine drainage [10] and in many clinically relevant environments such as
medical implants, lungs of cystic fibrosis patients, and dental plaques [83]. Because of their protective
polysaccharide coating, biofilms are often difficult to treat with antibiotics [83], and phage therapy has
been proposed as a potential treatment for antibiotic-resistant bacterial colonies. Høyland-Kroghsbo
et al. posited that upregulation of CRISPR-Cas could pose a challenge to potential phage therapies
for biofilms [26]. If such a biofilm-bound population is in the bistable regime we find, there may be a
way to prime the population in way that pushes it to the low CRISPR-Cas expression state to utilize
phage therapy effectively. More broadly, in a resource-limited environment, for example, a bacterial
population may do better to maintain a low density and avoid phage predation while repressing the
expression of Cas proteins, but consequently may lose their CRISPR-Cas system entirely. These
ecological constraints may shed light on why CRISPR-Cas is neither universal nor uncommon in the
microbial world.
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